Ueno Hideki 上野秀樹

… Alternative Names

上野秀樹ウエノヒデキ

Less

Researcher Number	10307522
Affiliation (Current)	2025: 国立研究開発法人国立がん研究センター, 中央病院, 医長 2025: 東京医科大学, 医学部, 兼任講師
Affiliation (based on the past Project Information) *help	2015 – 2017: 国立研究開発法人国立がん研究センター, 中央病院, 医長 2014: 独立行政法人国立がん研究センター, 中央病院, 医長
Review Section/Research Field	Principal Investigator Gastroenterology
Keywords	Principal Investigator 遺伝子変異 / がん遺伝子 / KRAS / トランスレーショナルリサーチ / 遺伝子 / 癌 / KRAS遺伝子変異 / 治療標的 / 遺伝子融合 / 膵がん

クロマチン制御遺伝子欠損による脆弱性を標的とした膵がん治療アイデアの確立Principal Investigator
- Principal Investigator
  
  上野秀樹
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  National Cancer Center Japan
Driver and druggable oncogene aberrations in KRAS mutation-negative pancreatic ductal adenocarcinomaPrincipal Investigator
- Principal Investigator
  
  Ueno Hideki
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  National Cancer Center Japan

All 2017 2015 Other

All Journal Article Presentation

[Journal Article] An Oncogenic ALK Fusion and an RRAS Mutation in KRAS Mutation-Negative Pancreatic Ductal Adenocarcinoma2017
- Author(s)
  Shimada Y, Kohno T, Ueno H, Ino Y, Hayashi H, Nakaoku T, Sakamoto Y, Kondo S, Morizane C, Shimada K, Okusaka T, Hiraoka N.
- Journal Title
  
  Oncologist
  
  Volume: 22 Issue: 2 Pages: 158-164
- DOI
  10.1634/theoncologist.2016-0194
- Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461039
[Journal Article] Utility of Assessing the Number of Mutated KRAS, CDKN2A, TP53, and SMAD4 Genes Using a Targeted Deep Sequencing Assay as a Prognostic Biomarker for Pancreatic Cancer.2017
- Author(s)
  Hayashi H, Kohno T, Ueno H, Hiraoka N, Kondo S, Saito M, Shimada Y, Ichikawa H, Kato M, Shibata T, Morizane C, Sakamoto Y, Shimada K, Komatsu Y, Sakamoto N, Okusaka T
- Journal Title
  
  Pancreas
  
  Volume: 46 Issue: 3 Pages: 335-340
- DOI
  10.1097/mpa.0000000000000760
- Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461039
[Journal Article] 【膵・胆道癌診療の新時代へ-診断と治療の新たな展開-】次世代シークエンサーを用いた膵癌遺伝子プロファイリング2015
- Author(s)
  林秀幸, 上野秀樹, 河野隆志
- Journal Title
  
  胆と膵
  
  Volume: 36 Pages: 131-134
- Data Source
  KAKENHI-PROJECT-26461039
[Journal Article] 【膵・胆道癌診療の新時代へ-診断と治療の新たな展開-】次世代シークエンサーを用いた膵癌遺伝子プロファイリング2015
- Author(s)
  林秀幸, 上野秀樹, 河野隆志
- Journal Title
  
  胆と膵
  
  Volume: 36 Pages: 131-134
- Data Source
  KAKENHI-PROJECT-26461039
[Presentation] Gene aberration profile of pancreatic cancer in Japanese patients
- Author(s)
  Hayashi H, Ueno H, Sakamoto Y, Kondo S, Morizane C, Shimada K, Ichikawa H, Hiraoka N, Kohno T, OKusaka T
- Organizer
  第12回日本臨床腫瘍学会学術集会
- Place of Presentation
  福岡
- Year and Date
  2014-07-17 – 2014-07-19
- Data Source
  KAKENHI-PROJECT-26461039
[Presentation] Gene mutation profile of pancreatic cancer obtained using targeted deep sequencing and its association with prognosis
- Author(s)
  Hayashi H, Ueno H, Sakamoto Y, Kondo S, Morizane C, Saito M, Shimada K, Ichikawa H, Hiraoka N, Kohno T, OKusaka T
- Organizer
  ESMO (EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY) 2014 Congress
- Place of Presentation
  Madrid, Spain
- Year and Date
  2014-09-26 – 2014-09-30
- Data Source
  KAKENHI-PROJECT-26461039

1. 奥坂拓志 (70501849)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results

Ueno Hideki 上野 秀樹

上野 秀樹 ウエノ ヒデキ

Research Projects

Research Products

Co-Researchers

クロマチン制御遺伝子欠損による脆弱性を標的とした膵がん治療アイデアの確立Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Driver and druggable oncogene aberrations in KRAS mutation-negative pancreatic ductal adenocarcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] An Oncogenic ALK Fusion and an RRAS Mutation in KRAS Mutation-Negative Pancreatic Ductal Adenocarcinoma2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Utility of Assessing the Number of Mutated KRAS, CDKN2A, TP53, and SMAD4 Genes Using a Targeted Deep Sequencing Assay as a Prognostic Biomarker for Pancreatic Cancer.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 【膵・胆道癌診療の新時代へ-診断と治療の新た な展開-】 次世代シークエンサーを用いた膵癌遺伝子プロファイリング2015

Author(s)

Journal Title

Data Source

[Journal Article] 【膵・胆道癌診療の新時代へ-診断と治療の新たな展開-】 次世代シークエンサーを用いた膵癌遺伝子プロファイリング2015

Author(s)

Journal Title

Data Source

[Presentation] Gene aberration profile of pancreatic cancer in Japanese patients

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Gene mutation profile of pancreatic cancer obtained using targeted deep sequencing and its association with prognosis

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

Ueno Hideki 上野秀樹

上野秀樹ウエノヒデキ

[Journal Article] 【膵・胆道癌診療の新時代へ-診断と治療の新たな展開-】次世代シークエンサーを用いた膵癌遺伝子プロファイリング2015

[Journal Article] 【膵・胆道癌診療の新時代へ-診断と治療の新たな展開-】次世代シークエンサーを用いた膵癌遺伝子プロファイリング2015